These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2410647)

  • 1. Role of natural killer (NK) cells and interferon in self-defense mechanisms.
    Kumagai K
    Jpn J Med; 1985 May; 24(2):183-6. PubMed ID: 2410647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symposium on mechanisms of host defense from fundamental and clinical medicine. 2. Role of natural killer (NK) cells and interferon in self-defense mechanisms].
    Kumagai K
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1747-51. PubMed ID: 6085342
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the NK lytic process involved in the mechanism of NK suppression of antibody-producing cells?
    Targan S; Brieva J; Newman W; Stevens R
    J Immunol; 1985 Feb; 134(2):666-9. PubMed ID: 2578158
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2.
    Kariya Y; Inoue N; Kihara T; Okamoto N; Sugie K; Mori T; Uchida A
    Immunol Lett; 1992 Feb; 31(3):241-5. PubMed ID: 1372283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte-mediated cytotoxicity.
    Herberman RB
    Pediatr Ann; 1987 Jun; 16(6):485, 488-93. PubMed ID: 2441344
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of cytotoxic activity of natural killer cells by interleukin 2, and antagonism between interleukin 2 and adenosine cyclic monophosphate.
    Chun M; Krim M; Granelli-Piperno A; Hirst JA; Hoffmann MK
    Scand J Immunol; 1985 Oct; 22(4):375-81. PubMed ID: 2416040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells and interferon.
    Welsh RM
    Crit Rev Immunol; 1984; 5(1):55-93. PubMed ID: 6085941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
    Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
    J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of natural killer cells in virus infections of mice.
    Welsh RM; Biron CA; Bukowski JF; McIntyre KW; Yang H
    Surv Synth Pathol Res; 1984; 3(5):409-31. PubMed ID: 6084280
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer cells--toward clinical application.
    Schattner A; Duggan DB
    Am J Hematol; 1985 Apr; 18(4):435-43. PubMed ID: 2579549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukins, interferon and rheumatic disease.
    Talal N
    Clin Rheum Dis; 1985 Dec; 11(3):633-44. PubMed ID: 2416506
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant interleukin 2 rapidly augments human natural killer cell activity.
    Kabelitz D; Kirchner H; Armerding D; Wagner H
    Cell Immunol; 1985 Jun; 93(1):38-45. PubMed ID: 2581709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
    Rupniewska ZM; Adamczyk MB
    Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
    [No Abstract]   [Full Text] [Related]  

  • 14. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
    Trinchieri G; Santoli D; Granato D; Perussia B
    Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon and natural cytotoxicity].
    Skurska Z
    Postepy Hig Med Dosw; 1984; 38(5-6):615-32. PubMed ID: 6085589
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
    Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus.
    Schrier RD; Rice GP; Oldstone MB
    J Infect Dis; 1986 Jun; 153(6):1084-91. PubMed ID: 2422296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.
    Bandyopadhyay S; Miller DS; Matsumoto-Kobayashi M; Clark SC; Starr SE
    Clin Exp Immunol; 1987 Feb; 67(2):372-82. PubMed ID: 2440628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of natural killer and interleukin 2-activated natural killer cell cytotoxicity by monosaccharides and lectins].
    Imir T; Bankhurst AD
    Mikrobiyol Bul; 1987 Oct; 21(4):245-50. PubMed ID: 3509759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.